150 related articles for article (PubMed ID: 8523500)
1. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men.
Torres-Alanís O; Garza-Ocañas L; Pineyro-Lopez A
J Toxicol Clin Toxicol; 1995; 33(6):717-20. PubMed ID: 8523500
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
[TBL] [Abstract][Full Text] [Related]
3. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A
J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436
[TBL] [Abstract][Full Text] [Related]
4. The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval).
Böse-O'Reilly S; Drasch G; Beinhoff C; Maydl S; Vosko MR; Roider G; Dzaja D
Sci Total Environ; 2003 May; 307(1-3):71-82. PubMed ID: 12711426
[TBL] [Abstract][Full Text] [Related]
5. Increase of renal excretion of organo-mercury compounds like methlymercury by DMPS (2,3-Dimercapto-1-propanesulfonic acid, Dimaval).
Drasch G; Boese-O'Reilly S; Illig S
Clin Toxicol (Phila); 2007; 45(3):266-9. PubMed ID: 17453878
[TBL] [Abstract][Full Text] [Related]
6. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
Chan TY
Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
[TBL] [Abstract][Full Text] [Related]
7. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water.
Guha Mazumder DN; De BK; Santra A; Ghosh N; Das S; Lahiri S; Das T
J Toxicol Clin Toxicol; 2001; 39(7):665-74. PubMed ID: 11778664
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning.
Campbell JR; Clarkson TW; Omar MD
JAMA; 1986 Dec; 256(22):3127-30. PubMed ID: 3783847
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Rummel KT; Woods JS
Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
[TBL] [Abstract][Full Text] [Related]
10. [The mercury exposure of the population. III. Mercury mobilisation by DMPS (Dimaval) in subjects with and without amalgam fillings].
Zander D; Ewers U; Freier I; Brockhaus A
Zentralbl Hyg Umweltmed; 1992 Feb; 192(5):447-54. PubMed ID: 1554403
[TBL] [Abstract][Full Text] [Related]
11. Fixed drug eruption due To 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect.
Erden F; Agis ER; Gunduzoz M; Yilmaz OH
Acta Clin Belg; 2019 Jun; 74(3):200-202. PubMed ID: 29912651
[TBL] [Abstract][Full Text] [Related]
12. Chelation therapy in intoxications with mercury, lead and copper.
Cao Y; Skaug MA; Andersen O; Aaseth J
J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
[TBL] [Abstract][Full Text] [Related]
13. [Exacerbation of pustular psoriasis in mercury poisoning].
Wehner-Caroli J; Scherwitz C; Schweinsberg F; Fierlbeck G
Hautarzt; 1994 Oct; 45(10):708-10. PubMed ID: 8002339
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of mercury poisoning in mercury refinery workers.
He FS; Zhow XR; Lin BX; Xiung YP; Chen SY; Zhang SL; Ru JY; Deng MH
Ann Acad Med Singap; 1984 Apr; 13(2 Suppl):389-93. PubMed ID: 6497343
[TBL] [Abstract][Full Text] [Related]
15. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
Aposhian HV
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Woods JS
Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
[TBL] [Abstract][Full Text] [Related]
17. DMPS can reverse the features of severe mercury vapor-induced neurological damage.
Bradberry SM; Sheehan TM; Barraclough CR; Vale JA
Clin Toxicol (Phila); 2009 Nov; 47(9):894-8. PubMed ID: 19852623
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis.
Yawei S; Jianhai L; Junxiu Z; Xiaobo P; Zewu Q
BMC Pharmacol Toxicol; 2021 May; 22(1):25. PubMed ID: 33941274
[TBL] [Abstract][Full Text] [Related]
19. Mercury kinetics in a case of severe mercuric chloride poisoning treated with dimercapto-1-propane sulphonate (DMPS).
Toet AE; van Dijk A; Savelkoul TJ; Meulenbelt J
Hum Exp Toxicol; 1994 Jan; 13(1):11-6. PubMed ID: 8198824
[TBL] [Abstract][Full Text] [Related]
20. Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings.
Stenman S; Grans L
Scand J Work Environ Health; 1997; 23 Suppl 3():59-63. PubMed ID: 9456068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
